Use of Coconut Nourish and Queen Garnet Plum to Improve Health in an Elderly Population

University of Manitoba

Status

Terminated

Conditions

Healthy Ageing

Treatments

Other: Treatment cookies

Other: Control cookies

Study type

Interventional

Funder types

Other

Identifiers

NCT03594097

HS21905 (B2018:052)

Details and patient eligibility

About

The purpose of this study is to identify whether the combination of coconut Nourish and Queen Garnet plum are able to attenuate ageing-related complications, including muscle mass loss and inflammation. The study endpoints will measure muscle mass as the primary endpoint with blood lipids, glucose, blood pressure, and inflammatory markers serving as some of the secondary endpoints. As the two products are rich in dietary fibre and anthocyanins, respectively, the study outcome will help to understand role of these dietary components in improving complications that are seen quite frequently in elderly population.

Enrollment

7 patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Aged 65 years and above
Able to give written informed consent
Able to read, write and speak English
Body mass index less than or equal to 30 kg/m^2
Either do not suffer from a chronic disease or, if suffering from a chronic disease, then key parameters (blood pressure, blood lipids concentration and blood glucose concentrations) are within the normal physiological range
Either take no chronic medication or have been treated with a stable dosage of medication for at least 3 months as confirmed by family physician.
Either take no supplements, or have been utilizing supplements in a stable and consistent dose for at least 3 months, and plan to continue taking a stable and consistent dose throughout the entire study.

Exclusion criteria

Smokers
Consumption of more than 2 alcoholic drinks/day, or > 14 alcoholic beverages a week, or history of alcoholism or drug dependence
Uncontrolled hypertension, recent stroke or myocardial infarction, hypothyroidism, diabetes mellitus or kidney disease
Major disability or disorder requiring continuous medical attention and treatment such as chronic heart failure, liver disease, renal failure or cancer, chronic infections or major surgery within 6 months prior to randomization
Despite taking medication, do not have values for key parameters (blood pressure, blood lipids concentration and blood glucose concentrations) within normal physiological ranges
Fasting glucose ≥ 5.6 mmol/L
Triglycerides ≥ 1.7 mmol/L
Systolic and diastolic blood pressures ≥130/85 mmHg
High-density lipoprotein cholesterol ≤1.0 mmol/L
Have gained or lost >10 lbs in the previous 3 months, or plan to lose weight at any time during the study
History of allergy to coconut, plum, plain flour, butter or milk
Any planned surgeries during the study